360 related articles for article (PubMed ID: 15250833)
1. Salivary secretory leukocyte protease inhibitor increases in HIV infection.
Lin AL; Johnson DA; Stephan KT; Yeh CK
J Oral Pathol Med; 2004 Aug; 33(7):410-6. PubMed ID: 15250833
[TBL] [Abstract][Full Text] [Related]
2. Salivary gland function in HIV-infected patients treated with highly active antiretroviral therapy (HAART).
Lin AL; Johnson DA; Sims CA; Stephan KT; Yeh CK
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):318-24. PubMed ID: 16920540
[TBL] [Abstract][Full Text] [Related]
3. Secretory leukocyte protease inhibitor and its potential interactions with elastase and cathepsin B in gingival crevicular fluid and saliva from patients with chronic periodontitis.
Cox SW; Rodriguez-Gonzalez EM; Booth V; Eley BM
J Periodontal Res; 2006 Oct; 41(5):477-85. PubMed ID: 16953825
[TBL] [Abstract][Full Text] [Related]
4. Salivary secretion, mucin concentrations and Candida carriage in HIV-infected patients.
Jainkittivong A; Lin AL; Johnson DA; Langlais RP; Yeh CK
Oral Dis; 2009 Apr; 15(3):229-34. PubMed ID: 19207880
[TBL] [Abstract][Full Text] [Related]
5. A 4-year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women's Interagency HIV Study participants.
Navazesh M; Mulligan R; Barrón Y; Redford M; Greenspan D; Alves M; Phelan J;
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jun; 95(6):693-8. PubMed ID: 12789150
[TBL] [Abstract][Full Text] [Related]
6. HIV infection, as opposed to antiretroviral therapy, does not cause changes in the concentration levels of specific salivary electrolytes.
Biocina-Lukenda D; Blazić-Potocki Z; Lukenda J; Potocki-Karacić T
Coll Antropol; 2009 Mar; 33(1):93-7. PubMed ID: 19408610
[TBL] [Abstract][Full Text] [Related]
7. Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues.
Wahl SM; Worley P; Jin W; McNeely TB; Eisenberg S; Fasching C; Orenstein JM; Janoff EN
Am J Pathol; 1997 Apr; 150(4):1275-84. PubMed ID: 9094984
[TBL] [Abstract][Full Text] [Related]
8. Endogenous mucosal antiviral factors of the oral cavity.
Shugars DC
J Infect Dis; 1999 May; 179 Suppl 3():S431-5. PubMed ID: 10099113
[TBL] [Abstract][Full Text] [Related]
9. Expression of oral secretory leukocyte protease inhibitor in HIV-infected subjects with long-term use of antiretroviral therapy.
Nittayananta W; Kemapunmanus M; Yangngam S; Talungchit S; Sriplung H
J Oral Pathol Med; 2013 Mar; 42(3):208-15. PubMed ID: 23126266
[TBL] [Abstract][Full Text] [Related]
10. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory function of secretory leukocyte proteinase inhibitor (SLPI) in human saliva is HIV-1 specific and varies with virus tropism.
Skott P; Lucht E; Ehnlund M; Björling E
Oral Dis; 2002 May; 8(3):160-7. PubMed ID: 12108760
[TBL] [Abstract][Full Text] [Related]
12. The effect of parotid salivary flow rate on the levels of salivary antimicrobial proteins in patients with Sjögren's syndrome.
Zipp MM; Yasbin L; al-Hashimi I
Quintessence Int; 1999 Oct; 30(10):700-5. PubMed ID: 10765854
[TBL] [Abstract][Full Text] [Related]
13. Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission.
Pillay K; Coutsoudis A; Agadzi-Naqvi AK; Kuhn L; Coovadia HM; Janoff EN
J Infect Dis; 2001 Feb; 183(4):653-6. PubMed ID: 11170993
[TBL] [Abstract][Full Text] [Related]
14. Enhanced secretory leukocyte protease inhibitor in human immunodeficiency virus type 1-infected patients.
Baqui AA; Meiller TF; Falkler WA
Clin Diagn Lab Immunol; 1999 Nov; 6(6):808-11. PubMed ID: 10548568
[TBL] [Abstract][Full Text] [Related]
15. Salivary concentration of secretory leukocyte protease inhibitor, an antimicrobial protein, is decreased with advanced age.
Shugars DC; Watkins CA; Cowen HJ
Gerontology; 2001; 47(5):246-53. PubMed ID: 11490143
[TBL] [Abstract][Full Text] [Related]
16. Parotid salivary basic proline-rich proteins inhibit HIV-I infectivity.
Robinovitch MR; Ashley RL; Iversen JM; Vigoren EM; Oppenheim FG; Lamkin M
Oral Dis; 2001 Mar; 7(2):86-93. PubMed ID: 11355444
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori infection, but not low-dose aspirin, results in a local reduction of the secretory leukocyte protease inhibitor in gastroduodenal mucosa.
Wex T; Ye S; Treiber G; Vieth M; Roessner A; Malfertheiner P
Helicobacter; 2006 Feb; 11(1):31-8. PubMed ID: 16423087
[TBL] [Abstract][Full Text] [Related]
18. Endogenous salivary inhibitors of human immunodeficiency virus.
Shugars DC; Alexander AL; Fu K; Freel SA
Arch Oral Biol; 1999 Jun; 44(6):445-53. PubMed ID: 10401522
[TBL] [Abstract][Full Text] [Related]
19. Secreted leukocyte protease inhibitor is present in aqueous humours from cataracts and other eye pathologies.
Janciauskiene S; Brandt L; Wallmark A; Westin U; Krakau T
Exp Eye Res; 2006 Mar; 82(3):505-11. PubMed ID: 16202405
[TBL] [Abstract][Full Text] [Related]
20. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
